Investing in Medical Nanotechnologies will showcase the present-day investment opportunities in nanomedicine across Europe. The conference is expected to bring together investors, start up nanotechnology companies, patent and licencing executives, regulatory authorities, corporate research scientists, technology transfer experts and government agencies. The event will showcase the state-of-the-art scientific developments on the healthcare applications of nanotechnology.

Applications are now being sought from organisations with products or prototypes, interested in presenting their work to prominent investors from both the financial and corporate sectors.  An exhibition presenting nanotechnology products and solutions for medicine and healthcare will complement the top-level conference. 

• Personalized medicine
• Targeted Drug Delivery
• Functionalised Nanoparticles
• Analytical and Diagnostic Techniques
• Regenerative Medicine

• Nanobiomaterials
• Body-friendly Implants
• Nanotechnology in Imaging
• Treatments for Degenerative Diseases
• Converging Technologies for Healthcare Applications

• Dr. Philippe Cleuziat
  Strategy Management Director, Molecular Biology, bioMérieux
• Dr. Thomas K. Epprecht
  Senior Risk Specialist, Swiss Reinsurance Company
• Dr. Leonard Fass
  Director, Academic Relations, GE Healthcare
• Ogan Gurel
  CEO, Duravest,Inc.
• Kim Kreilgaard
  Head of Research, Development and Innovation Division, European Investment Bank
• Prof. Sir Michael Rawlins
  Chairman, National Institute of Clinical Excellence, UK
• Dr. Paul Smit
  Senior Vice President, Philips Medical Systems